Dataset from A Phase 2a Study to Evaluate the Effect of Rilapladib (SB-659032) on Biomarkers Related to the Pathogenesis and Progression of Alzheimer's Disease

Name: Dataset from A Phase 2a Study to Evaluate the Effect of Rilapladib (SB-659032) on Biomarkers Related to the Pathogenesis and Progression of Alzheimer's Disease
Creator: 暂无描述
License: 暂无描述

NIAID Data Ecosystem2026-05-02 收录

下载链接：

https://doi.org/10.25934/00001078

下载链接

链接失效反馈

官方服务：

资源简介：

The study is designed to investigate the effects of rilapladib on biomarkers related to the Alzheimer's disease, and cognitive function.

创建时间：

2024-11-26